Search

Your search keyword '"Yang, Jeong-Sun"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Yang, Jeong-Sun" Remove constraint Author: "Yang, Jeong-Sun"
236 results on '"Yang, Jeong-Sun"'

Search Results

3. Experimental Infection and Transmission of SARS-CoV-2 Delta and Omicron Variants among Beagle Dogs

6. The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation.

8. Differential beta‐coronavirus infection dynamics in human bronchial epithelial organoids

9. Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

10. The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.

11. 1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study

12. Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID‐19: A prospective cohort study

13. Mutational analysis of severe acute respiratory syndrome coronavirus 2 in immunocompromised patients with persistent viral detection using whole genome sequencing

14. A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

17. Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding

18. Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study

21. Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?

22. Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

23. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection

24. Variations in spike glycoprotein gene of MERS-CoV, South Korea, 2015

25. Middle east respiratory syndrome in 3 persons, South Korea, 2015

27. Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells

29. Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study

34. Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS‐CoV‐2 infection

36. Longitudinal Analysis of Memory T-Cell Responses in Survivors of Middle East Respiratory Syndrome

40. Longitudinal Analysis of Memory T-Cell Responses in Survivors of Middle East Respiratory Syndrome.

41. The in vitro and in vivo potency of CT-P59 against Delta and its associated variants of SARS-CoV-2

43. Longitudinal Assessment of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019

46. Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability

49. A Novel Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2

50. Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability

Catalog

Books, media, physical & digital resources